140 related articles for article (PubMed ID: 35272357)
1. Efficacy and Safety of Combined Embolization and Radiofrequency Ablation in Stage 1 Renal Cell Carcinomas.
Wessendorf J; König AM; Heers H; Mahnken AH
Rofo; 2022 Sep; 194(9):1020-1025. PubMed ID: 35272357
[TBL] [Abstract][Full Text] [Related]
2. Repeat Percutaneous Radiofrequency Ablation of T1 Renal Cell Carcinomas is Safe in Patients with Von Hippel-Lindau Disease.
Wessendorf J; König A; Heers H; Mahnken AH
Cardiovasc Intervent Radiol; 2021 Dec; 44(12):2022-2025. PubMed ID: 34414496
[TBL] [Abstract][Full Text] [Related]
3. Transarterial embolization (TAE) as add-on to percutaneous radiofrequency ablation (RFA) for the treatment of renal tumors: Review of the literature, overview of state-of-the-art embolization materials and further perspective of advanced image-guided tumor ablation.
Sommer CM; Pallwein-Prettner L; Vollherbst DF; Seidel R; Rieder C; Radeleff BA; Kauczor HU; Wacker F; Richter GM; Bücker A; Rodt T; Massmann A; Pereira PL
Eur J Radiol; 2017 Jan; 86():143-162. PubMed ID: 28027741
[TBL] [Abstract][Full Text] [Related]
4. Sequential combination treatment (arterial embolization and percutaneous radiofrequency ablation) of inoperable renal cell carcinoma: single-center pilot study.
Nakasone Y; Kawanaka K; Ikeda O; Tamura Y; Yamashita Y
Acta Radiol; 2012 May; 53(4):410-4. PubMed ID: 22393159
[TBL] [Abstract][Full Text] [Related]
5. Radiofrequency ablation in combination with embolization in metachronous recurrent renal cancer in solitary kidney after contralateral tumor nephrectomy.
Gebauer B; Werk M; Lopez-Hänninen E; Felix R; Althaus P
Cardiovasc Intervent Radiol; 2007; 30(4):644-9. PubMed ID: 17436034
[TBL] [Abstract][Full Text] [Related]
6. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas.
Zagoria RJ; Traver MA; Werle DM; Perini M; Hayasaka S; Clark PE
AJR Am J Roentgenol; 2007 Aug; 189(2):429-36. PubMed ID: 17646471
[TBL] [Abstract][Full Text] [Related]
7. Safety and oncological outcome following radiofrequency ablation of small renal masses in a single center.
Bersang AB; Søndergaard Mosholt KS; Verner Jensen C; Germer U; Holm M; Røder MA
Scand J Urol; 2021 Jun; 55(3):203-208. PubMed ID: 33739218
[TBL] [Abstract][Full Text] [Related]
8. Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.
Forauer AR; Dewey BJ; Seigne JD
Urol Oncol; 2014 Aug; 32(6):869-76. PubMed ID: 24946958
[TBL] [Abstract][Full Text] [Related]
9. Application of contrast-enhanced ultrasonography after radiofrequency ablation for renal cell carcinoma: is it sufficient for assessment of therapeutic response?
Kong WT; Zhang WW; Guo HQ; Qiu JL; Tang M; Jiang ZM; Shen Y; Li XG; Zhang SW
Abdom Imaging; 2011 Jun; 36(3):342-7. PubMed ID: 21107560
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up.
Arima K; Yamakado K; Kinbara H; Nakatsuka A; Takeda K; Sugimura Y
Int J Urol; 2007 Jul; 14(7):585-90; discussion 590. PubMed ID: 17645597
[TBL] [Abstract][Full Text] [Related]
11. MRI-guided percutaneous laser ablation of small renal cell carcinoma: Initial clinical experience.
Kariniemi J; Ojala R; Hellström P; Sequeiros RB
Acta Radiol; 2010 May; 51(4):467-72. PubMed ID: 20380606
[TBL] [Abstract][Full Text] [Related]
12. [Long-term follow-up of renal cell carcinomas T1a treated by percutaneous radiofrequency].
Amadane N; André M; Daniel L; Coulange C; Baboudjian M; Michel F; Gondran-Tellier B; Vanacore D; Lechevallier E; Boissier R
Prog Urol; 2021 Sep; 31(10):576-583. PubMed ID: 33593696
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of CT-guided microwave ablation for stage T1a renal cell carcinoma in patients with a solitary kidney.
Meng H; Yang H; Jia H; Pan F; Dong X; Liu B; Li C
Int J Hyperthermia; 2021; 38(1):691-695. PubMed ID: 33899668
[TBL] [Abstract][Full Text] [Related]
14. Radiofrequency ablation of small renal cell carcinomas using multitined expandable electrodes: preliminary experience.
Clark TW; Malkowicz B; Stavropoulos SW; Sanchez R; Soulen MC; Itkin M; Patel A; Mondschein JI; Wein AJ
J Vasc Interv Radiol; 2006 Mar; 17(3):513-9. PubMed ID: 16567676
[TBL] [Abstract][Full Text] [Related]
15. Radiofrequency ablation for the treatment of small renal masses: safety and oncologic efficacy.
Joniau S; Tsivian M; Gontero P
Minerva Urol Nefrol; 2011 Sep; 63(3):227-36. PubMed ID: 21993321
[TBL] [Abstract][Full Text] [Related]
16. Radiofrequency ablation combined with renal arterial embolization for the treatment of unresectable renal cell carcinoma larger than 3.5 cm: initial experience.
Yamakado K; Nakatsuka A; Kobayashi S; Akeboshi M; Takaki H; Kariya Z; Kinbara H; Arima K; Yanagawa M; Hori Y; Kato H; Sugimura Y; Takeda K
Cardiovasc Intervent Radiol; 2006; 29(3):389-94. PubMed ID: 16502180
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and safety of computed tomography-guided radiofrequency ablation of renal cancer: a 14-year single institution experience in 203 patients.
Iannuccilli JD; Dupuy DE; Beland MD; Machan JT; Golijanin DJ; Mayo-Smith WW
Eur Radiol; 2016 Jun; 26(6):1656-64. PubMed ID: 26373755
[TBL] [Abstract][Full Text] [Related]
18. [Percutaneous CT-guided radiofrequency ablation for small renal masses : A retrospective, single center data analysis].
Heißler O; Seklehner S; Fellner H; Engelhardt PF; Chemelli A; Riedl C
Urologe A; 2018 Jul; 57(7):828-835. PubMed ID: 29797025
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous Radiofrequency Ablation Versus Robotic-Assisted Partial Nephrectomy for the Treatment of Small Renal Cell Carcinoma.
Pantelidou M; Challacombe B; McGrath A; Brown M; Ilyas S; Katsanos K; Adam A
Cardiovasc Intervent Radiol; 2016 Nov; 39(11):1595-1603. PubMed ID: 27435582
[TBL] [Abstract][Full Text] [Related]
20. Incidence of multiple sporadic renal cell carcinomas in patients referred for renal radiofrequency ablation: implications for imaging follow-up.
Beland MD; Wolf FJ; Grand DJ; Dupuy DE; Mayo-Smith WW
AJR Am J Roentgenol; 2011 Sep; 197(3):671-5. PubMed ID: 21862810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]